BACs-on-Beads, Prenatal diagnosis, Products of conception
Citation Information :
Onsod P, Jaranasaksakul W, Areesirisuk P, Parinayok R, Rerkamnuaychoke B, Chareonsirisuthigul T. Rapid Molecular Karyotyping for Products of Conception by BACs-on-beads Technology. Int J Infertil Fetal Med 2022; 13 (2):61-66.
Aim: Bacterial artificial chromosomes (BACs)-on-beads (BoBs) technology detects aneuploidy, chromosome gains, and losses. The Prenatal™ BoBs detect common aneuploidies and nine microdeletion syndromes. The KaryoLite™ BoBs additionally detect alterations in the p and q arm of all chromosomes. We evaluated BoBs technology for the product of conception (POC) screening.
Materials and methods: A total of 265 fresh POC were evaluated by the different BoBs (233 KaryoLite™ BoBs, nine Prenatal™ BoBs, and 23 of both).
Results: BoBs detected chromosomal abnormalities in 142 samples (53.58%). The most frequent chromosome abnormality was trisomy 21 (17.61%), followed by monosomy X, trisomy 16, and trisomy 22 (14.08%). Twenty-three samples (13 normal and 10 abnormal), which used both KaryoLite™ and Prenatal™ BoBs kits, were concordant. Moreover, BoBs techniques had no failure rate.
Conclusion: BoBs technology is a potentially useful method for diagnosing common aneuploidies and microdeletion syndromes in conception products. This method's advantage over cell culture includes quicker results and a lower failure rate.
Warren JE, Silver RM. Genetics of pregnancy loss. Clin Obstet Gynecol 2008;51(1):84–95. DOI: 10.1097/GRF.0b013e318161719c
Hassold T, Chen N, Funkhouser J, et al. A cytogenetic study of 1000 spontaneous abortions. Ann Hum Genet 1980;44(2):151–178. DOI: 10.1111/j.1469-1809.1980.tb00955.x
Perez-Duran J, Najera Z, Trujillo-Cabrera Y, et al. Aneusomy detection with Karyolite-Bac on Beads is a cost-efficient and high throughput strategy in the molecular analyses of the early pregnancy conception losses. Mol Cytogenet 2015;8:63. DOI: 10.1186/s13039-015-0168-x
Grati FR, Gomes DM, Ganesamoorthy D, et al. Application of a new molecular technique for the genetic evaluation of products of conception. Prenat Diagn 2013;33(1):32–41. DOI: 10.1002/pd.4004
Menasha J, Levy B, Hirschhorn K, et al. Incidence and spectrum of chromosome abnormalities in spontaneous abortions: new insights from a 12-year study. Genet Med 2005;7(4):251–263. DOI: 10.1097/01.gim.0000160075.96707.04
Gross SJ, Bajaj K, Garry D, et al. Rapid and novel prenatal molecular assay for detecting aneuploidies and microdeletion syndromes. Prenat Diagn 2011;31(3):259–266. DOI: 10.1002/pd.2674
Vialard F, Simoni G, Gomes DM, et al. Prenatal BACs-on-Beads: the prospective experience of five prenatal diagnosis laboratories. Prenat Diagn 2012;32(4):329–335. DOI: 10.1002/pd.2934
Shaffer LG. Diagnosis of microdeletion syndromes by fluorescence in situ hybridization (FISH). Curr Protoc Hum Genet 2001; Chapter 8: Unit 8.10. DOI: 10.1002/0471142905.hg0810s14
Vialard F, Simoni G, Aboura A, et al. Prenatal BACs-on-Beads: a new technology for rapid detection of aneuploidies and microdeletions in prenatal diagnosis. Prenat Diagn 2011;31(5):500–508. DOI: 10.1002/pd.2727
Dunbar. Applications of Luminex xMAP technology for rapid, high-throughput multiplexed nucleic acid detection. Clin Chim Acta 2006;363(1-2):71–82. DOI: 10.1016/j.cccn.2005.06.023
Garcia-Herrero S, Campos-Galindo I, Martinez-Conejero JA, et al. BACs-on-Beads technology: a reliable test for rapid detection of aneuploidies and microdeletions in prenatal diagnosis. Biomed Res Int 2014;2014:590298. DOI: 10.1155/2014/590298
Farra C, Nassar AH, Mirza F, et al. BACs-on-Beads assay, a rapid aneuploidy test, improves the diagnostic yield of conventional karyotyping. Mol Biol Rep 2020;47(1):169–177. DOI: 10.1007/s11033-019-05117-7
Wang BT, Chong TP, Boyar FZ, et al. Abnormalities in spontaneous abortions detected by G-banding and chromosomal microarray analysis (CMA) at a national reference laboratory. Mol Cytogenet 2014;7:33. DOI: 10.1186/1755-8166-7-33
Zhang T, Sun Y, Chen Z, et al. Traditional and molecular chromosomal abnormality analysis of products of conception in spontaneous and recurrent miscarriage. BJOG 2018;125(4):414–420. DOI: 10.1111/1471-0528.15052
Grati FR, Vialard F, Gross S. BACs-on-Beads™ (BoBs™) assay for the genetic evaluation of prenatal samples and products of conception. Methods Mol Biol 2015;1227:259–278. DOI: 10.1007/978-1-4939-1652-8_13
Mellali S, Haoud K, Gouas L, et al. Prenatal BoBsTM in the cytogenetic analysis of products of spontaneous miscarriage. S Afr Med J 2015;105(10):870–873. DOI: 10.7196/SAMJnew.8121
Paxton CN, Brothman AR, Geierebach KB. Rapid aneusomy detection in products of conception using the KaryoLite™ BACs-on-Beads™ assay. Prenat Diagn 2013;;33(1):25–31. DOI: 10.1002/pd.4003
Choy KW, Kwok YK, Cheng YK, et al. Diagnostic accuracy of the BACs-on-Beads assay versus karyotyping for prenatal detection of chromosomal abnormalities: a retrospective consecutive case series. BJOG 2014;121(10):1245–1252. DOI: 10.1111/1471-0528.12873